Primary Record
1,9-Pyrazoloanthrone
- In stock
- 9,321 g
- Purity
- 98.6 %
- CAS
- 129-56-6
Compound Identifiers & Properties
- CAS
- 129-56-6
- PubChem CID
- 8515
- SMILES
- C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O
- Canonical SMILES
- O=C1c2ccccc2-c2n[nH]c3cccc1c23
Names & Synonyms
- 1,9-Pyrazoloanthrone
- Pyrazolanthrone
- Pyrazoleanthrone
- SP600125
- 129-56-6
- Dibenzo[cd,g]indazol-6(2H)-one
- JNK Inhibitor II
- Anthra[1,9-cd]pyrazol-6(2H)-one
- Anthrapyrazolone
- SAPK Inhibitor II
- SP 600125
- Pyrazolanthrone;
- SP-600125
- Anthrapyrazolone;
- Anthra-1,9-pyrazol-6-none
- 1pmv
- 2zmd
- SAPK Inhibitor I
- 2H-Dibenzo[cd,g]indazol-6-one
- JNKII
- 1 9-pyrazoleanthrone
- SULFURIC ACID
- ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE
- C14H8N2O
- Kinome_3844
- Tocris-1496
- [?]one
- PYRAZOLE ANTHRONE
- 2h-dibenzo(cd,g)indazol-6-one
- MFCD00022289
- AC1Q6DQN
- BiomolKI_000068
- RefChem:113038
- timtec-bb sbb000595
- CHEMBL7064
- Lopac-S-5567
- C.I. 70300
- DTXSID2040525
- NSC 75890
- BiomolKI2_000072
- D00JXM
- D02PVB
- NSC75890
- AC1L1R5Y
- AC1Q6DR1
- AC1Q6DR2
- cid_8515
- MLS002693964
- ACPOUJIDANTYHO-UHFFFAOYSA-N
- CBiol_002049
- Lopac0_000473
- NSC-75890
- BMK1-G8
- BSPBio_001066
- ChemBiol10705 Compound 4
- Color Index No. 70300
- Color Index Number 70300
- DTXCID0020525
- KBioGR_000406
- KBioSS_000406
- UNII-1TW30Y2766
- cc-622
- CHEBI:90695
- Colour Index No. 70300
- dibenz[cd,g]indazol-6(2h)-one
- JMC517015 Compound 2
- KSC516G2D
- MLS002153267
- MLS006011577
- Colour Index Number 70300
- SCHEMBL170980
- EINECS 204-955-6
- anthra[1,9-cd]pyrazol-6-one
- GTPL5273
- orb1304531
- Pyrazolanthrone (SP600125)
- 1TW30Y2766
- c.i.70300
- CHEMBL1725279
- SCHEMBL15583517
- SCHEMBL29353146
- SCHEMBL29693577
- SCHEMBL29941507
- 4-Aminopyridine-2-carboxylicacid
- BCBcMAP01_000053
- BDBM16018
- CTK4B6321
- InSolution™ JNK Inhibitor II
- KBio2_000406
- KBio2_002974
- KBio2_005542
- KBio3_000771
- KBio3_000772
- BRN 0746890
- CID8515
- Bio1_000335
- Bio1_000824
- Bio1_001313
- Bio2_000373
- Bio2_000853
- GLXC-03091
- HMS1362F07
- HMS1667K13
- HMS1792F07
- HMS1990F07
- HMS2250C03
- HMS3229I16
- HMS3261O08
- HMS3267P06
- HMS3295M01
- HMS3403F07
- HMS3412F05
- HMS3654P10
- HMS3676F05
- HMS3747M19
- PS653
- ALBB-024051
- AMY31086
- Anthra[1,9cd]pyrazol-6(2H)-one
- BCP05457
- C14-H8-N2-O
- CID:8515
- EX-A1998
- Tox21_110267
- Tox21_500473
- Anthra[1-9-cd]pyrazol-6(2H)-one
- ANW-68872
- BDBM50024294
- BDBM50433916
- CCG-47500
- Dibenzo[cd,g]indazol-6(2H)-one #
- EBC-11070
- HB2234
- HSCI1_000136
- NCGC00015958-03
- NSC755773
- PS-653
- s1460
- SBB000595
- ZINC96298875
- CI 70300
- AKOS000115584
- AKOS040751313
- Anthra[1,9-cd]pyrazol-6(2H)-one;
- Anthrapyrazolone; 1,9-Pyrazoloanthrone
- CCG-100672
- CS-0196
- DB01782
- FP33726
- LP00473
- NSC-755773
- SDCCGSBI-0050458.P003
- SDCCGSBI-0050458.P009
- VA10299
- WLN: T C66651A P IV OMNJ
- 1,6-dihydrodibenzo[cd,g]indazol-6-one
- 2,6-dihydrodibenzo[cd,g]indazol-6-one
- IDI1_002128
- QTL1_000077
- s10332
- SMP2_000240
- NCGC00015958-01
- NCGC00015958-02
- NCGC00015958-04
- NCGC00015958-05
- NCGC00015958-06
- NCGC00015958-07
- NCGC00015958-08
- NCGC00015958-22
- NCGC00025186-01
- NCGC00025186-02
- NCGC00025186-03
- NCGC00025186-04
- NCGC00025186-05
- NCGC00261158-01
- WLN: T C6665 1A P IV OMNJ
- 2,6-DIHYDROANTHRA/1,9-CD/PYRAZOL-6-ONE
- AC-32051
- AJ-50631
- AK-57219
- AN-43643
- AS-14374
- BAS 00719687
- BC200202
- CAS-129-56-6
- CJ-11929
- HY-12041
- J55.382D
- JNK Inhibitor II - CAS 129-56-6
- K914
- LS-20607
- SC-62298
- SID:53787267
- SMR000015440
- SMR002530644
- ST018684
- SY052909
- 2,6-Dihydro-1,2-diazaaceanthrylene-6-one
- DB-041928
- SP600125?
- TC-157617
- TL8000704
- A2548
- A4604
- EU-0100473
- FT-0607068
- NS00020981
- ST24046474
- SW218106-2
- EN300-02083
- 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
- A10860
- Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100
- K00068
- S 5567
- SP600125, >=98% (HPLC)
- AB00075935-01
- SP 600125 & Z-100
- 129S566
- A888840
- AE-641/00620033
- C432165
- SR-01000075840
- Q4545713
- SR-01000075840-1
- SR-01000075840-2
- SR-01000075840-4
- SR-01000075840-6
- SR-01000637108-1
- BRD-K01567962-001-04-0
- BRD-K01567962-001-06-5
- BRD-K01567962-001-08-1
- BRD-K01567962-001-22-2
- BRD-K01567962-001-23-0
- BRD-K01567962-001-24-8
- Z56785477
- F1414-1245
- SP600125, 129-56-6
- Anthra[1,9-cd]pyrazol-6(2H)-one, 98% - 100MG 100mg
- dibenzo[cd,g]indazol-6(2H)-one; Anthra[1,9-cd]pyrazol-6(2H)-one
- 120093-15-4
- 14,15-diazatetracyclo(7.6.1.0^(2,7).0^(13,16))hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one
- 14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one
- 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one
- 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one
- 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
- 189681-71-8
- 204-955-6
- 7664-93-9